In addition, the association of EPAS1 DNA number changes and mRNA expression with clinical and pathological factors, including tumour weight, size, location and the type of tumour, denotes the potential clinical significance of EPAS1 in predicting disease progression. This evidence concerns the gene EPAS1 and neoplasm.